WPI describes how Ampligen boosts NK cell activity in XMRV-positive CFS patients’ cells

The following link is the abstract of a research paper by a team of University of Nevada/Whittemore Peterson Institute researchers. The paper will be presented May 9 to immunologists gathered in Baltimore at Immunology 2010™ by UN/WPI lead author Isabel Barao-Silvestre.

More @ ProHealth

Advertisements